HSPB1 and breast carcinoma: Heat shock protein beta-1 (HSPB1) binding to Ikβ-α and promoting its ubiquitin-mediated degradation can lead to the activation of NF-κB signal transduction, and inhibition of ferroptosis can upregulate the expression of HSPB1, thereby promoting the resistance to breast cancer treatment drugs [56].